The Evolution of a Life Science Board
Tom Murphy Senior Vice President Bench International How would you characterize the evolution of a corporate board of directors? Startup companies typically have the founder and ea
Bench International was recognized as one of the Top 50 Companies to Watch in 2021 by Silicon Review. DeeDee DeMan founded the executive search firm over 45 years ago to serve the Life Science and Healthcare sectors. Bench developed a new model for executive recruiting and became renowned experts in diversity recruitment at the board and executive level.
Our initiatives for 2021 are centered around supporting our clients in finding and cultivating diverse leaders, as the shareholders, doctors...
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do.
Tom Murphy Senior Vice President Bench International How would you characterize the evolution of a corporate board of directors? Startup companies typically have the founder and ea
Recent Key Placement: Vice President and Head of Discovery Biology – Blueprint Medicines – If you’re seeking to diversify your leadership team, or your board with hig
Natasha Allen Global SVP & Europe Region Head Bench International Why Life Science Executive Recruitment Firms Fail Their Clients – A View from Across the Pond Let’s start
DeeDee DeMan Founder, Chairman & Chief Executive Officer Bench International What are most significant recruiting shifts that you have seen in Life Sciences executive search ov
Bench International is pleased to announce the successful completion of the appointment of Brent Warner as President, Gene Therapy at Poseida Therapeutics. Read the Poseida Ther
Bench International is pleased to announce the successful completion of the appointment of Scott Shively as President and Chief Executive Officer, and member of the board of direc
Recent Key Placement: Vice President, Medical Affairs, Specimen Management – BD – If you’re seeking to diversify your leadership team, or your board with high impact
Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs Posted by Tom Murphy: The team at Ben
Recent Key Placement: David Eberhard MD, PhD as Chief Medical Officer – Inivata Liquid Biopsy a NeoGenomics, Inc. Subsidiary – If you’re seeking to diversify your leaders